Cystic fibrosis (CF) is an inherited condition that affects the lungs and digestive system. It causes the body to produce thick, sticky mucus that can clog the airways and block enzymes needed to digest food. Newborn screening for CF means many babies are identified before symptoms appear, so specialized care can begin early, when it makes the biggest difference to long-term health.
What causes cystic fibrosis
CF is caused by changes (variants) in the CFTR gene, which controls the movement of salt and water in and out of cells. When CFTR does not work properly, mucus in the lungs, pancreas, and other organs becomes thick and sticky. CF is inherited in an autosomal recessive pattern, so a child must inherit a variant from both parents. It is one of the more common inherited conditions, affecting roughly 1 in 3,000 to 4,000 newborns, with frequency varying by ancestry.
How newborn screening detects cystic fibrosis
CF is screened for in all U.S. states. The screen begins with a blood-spot test that measures a marker called immunoreactive trypsinogen (IRT). If IRT is high, many programs then test the same sample for common CFTR variants. Because screening flags babies who need further testing rather than diagnosing CF on its own, an out-of-range result is followed by a confirmatory sweat chloride test and evaluation at a CF care center.
How cystic fibrosis is managed
While there is no cure, CF is far more manageable than it once was, especially when care starts early. Treatment can include airway clearance techniques, medications, pancreatic enzyme supplements, careful nutrition, and, for many patients, CFTR modulator therapies that target the underlying problem. Early diagnosis through newborn screening supports better growth and lung health from the start.
Signs and symptoms of cystic fibrosis
Because newborn screening catches most cases early, many babies with CF have few or no symptoms at first. When signs do appear, they can include very salty-tasting skin, poor weight gain or slow growth despite a healthy appetite, greasy or bulky stools, frequent lung or sinus infections, a persistent cough, and wheezing. Symptoms and their severity vary widely from child to child. A positive screen or these signs should be evaluated by a CF care center, which can perform a confirmatory sweat chloride test.
How genetic screening fits in
State newborn screening catches CF well. Genetic screening looks directly at the CFTR gene and, in the same test, can assess the genes tied to more than 1,000 other clinically actionable childhood conditions, many not on any state panel. Fore Genomics offers an at-home cheek-swab screen, sequenced in CLIA-certified and CAP-accredited labs, with results supported by board-certified genetic counselors. See what we screen for or start screening.
Frequently asked questions
Is cystic fibrosis on every state’s newborn screening panel?
Yes. CF is screened for in all U.S. states, typically using an IRT blood test followed by DNA analysis.
Does a positive screen mean my baby has CF?
Not necessarily. Screening identifies babies who need further testing. A confirmatory sweat chloride test and specialist evaluation determine a diagnosis.
Is cystic fibrosis inherited?
Yes. CF is autosomal recessive, so a child inherits a CFTR variant from each parent, who are often unaffected carriers.
Medically reviewed by Fore’s Clinical Team. This article is for general educational purposes and is not medical advice. Sources: HRSA Newborn Screening; Cystic Fibrosis Foundation.